4162PharmaEngine4162 info
$2.68info0.46%24h
Global rank12855
Market cap$384.56M
Change 7d1.27%
YTD Performance-16.76%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    PharmaEngine (4162) Stock Overview

    PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It offers ONIVYDE, a novel and stable encapsulated chemotherapy drug irinotecan for the treatment of metastatic pancreatic cancer and other indications of clinical development. The company is developing PEP07, a checkpoint kinase 1 inhibitor, which is in preclinical development stage for the treatment of hematologic cancers and solid cancers, such as acute myeloid leukemia and mantle cell lymphoma. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.

    4162 Stock Information

    Symbol
    4162
    Address
    10 Minsheng East RoadTaipei, 104Taiwan
    Founded
    -
    Trading hours
    -
    Website
    https://www.pharmaengine.com
    Country
    πŸ‡ΉπŸ‡Ό Taiwan
    Phone Number
    886 2 2515 8228

    PharmaEngine (4162) Price Chart

    -
    Value:-

    PharmaEngine Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.68
    N/A
    Market Cap
    $384.56M
    N/A
    Shares Outstanding
    143.68M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org